MR evaluation of breast lesions obtained by diffusion-weighted imaging with background body signal suppression (DWIBS) and correlations with histological findings

Magnetic Resonance Imaging

Volumn 32, Issue 6, 2014, Pages 605-609

  Moschetta, Marco ^a   Telegrafo, Michele ^a   Rella, Leonarda ^a   Capolongo, Arcangela ^a   Stabile Ianora, Amato Antonio ^a   Angelelli, Giuseppe ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Breast; Diffusion; DWIBS; Magnetic resonance; MRI

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST LESION; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DIFFUSION WEIGHTED IMAGING WITH BACKGROUND BODY SIGNAL SUPPRESSION; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BREAST NEOPLASMS; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; ECHOMAMMOGRAPHY; MAMMOGRAPHY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES;

NUCLEOPOLYHEDROVIRUS;

CONTRAST MEDIUM;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 84901006188     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2014.03.009     Document Type: Article

References (34)

1. Heywang-Kobrunner S.H. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994, 29:94-104.
2. Orel S.G., Schnall M.D., Livolsi V.A., Troupin R.H. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994, 190:485-493.
3. Huang W., Fisher P.R., Dulaimy K., Tudorica L.A., O'Hea B., Button T.M. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004, 232:585-591.
4. Kuhl C.K. MRI of breast tumors. Eur Radiol 2000, 10:46-58.
5. Baum F., Fischer U., Vosshenrich R., Grabbe E. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 2002, 12:1087-1092.
6. Hoffmann U., Brix G., Knopp M.V., Hess T., Lorenz W.J. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995, 33:506-514.
7. Kuhl C.K., Mielcareck P., Klaschik S., Leutner C., Wardelmann E., Gieseke J., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999, 211:101-110.
8. Degani H., Gusis V., Weinstein D., Fields S., Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997, 3:780-782.
9. Orel S.G. High-resolution MR, imaging for the detection, diagnosis, and staging of breast cancer. RadioGraphics 1998, 18:903-912.
10. Vestito A., Mangieri F.F., Gatta G., Moschetta M., Turi B., Ancona A. Breast carcinoma in elderly women. Our experience. G Chir 2011, 32:411-416.
11. Belli P., Costantini M., Bufi E., Magistrelli A., La Torre G., Bonomo L. Diffusion-weightedimaging in breastlesionevaluation. Radiol Med 2010, 115:51-69.
12. Peters N.H., Borel Rinkes I.H., Zuithoff N.P., Mali W.P., Moons K.G., Peeters P.H. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008, 246:116-124.
13. Kul S., Cansu A., Alhan E., Dinc H., Gunes G., Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 2011, 196:210-217.
14. Pediconi F., Catalano C., Occhiato R., Venditti F., Fraioli F., Napoli A., et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: GadobenateDimeglumine versus Gadopentat Dimeglumine. Radiology 2005, 237:45-56.
15. Kuhl C.K., Jost P., Morakkabati N., Zivanovic O., Schild H.H., Gieseke J. Contrast-enhanced MR Imaging of the Breast at 3.0 and 1.5T in the Same Patients: Initial Experience. Radiology 2006, 239:666-676.
16. Rakow-Penner R., Daniel B., Yu H., Sawyer-Glover A., Glover G.H. Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL. J Magn Reson Imaging 2006, 23:87-91.
17. Bartella L., Morris E.A., Dershaw D.D., Liberman L., Thakur S.B., Moskowitz C., et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006, 239:686-692.
18. Bartella L., Morris E.A. Advances in breast imaging: magnetic resonance imaging. Curr Oncol Rep 2006, 8:7-13.
19. Fausto A., Magaldi A., Babaei Paskeh B., Menicagli L., Lupo E.N., Sardanelli F. MR imaging and proton spectroscopy of the breast: how to select the images useful to convey the diagnostic message. Radiol Med 2007, 112:1060-1068.
20. Sardanelli F., Fausto A., Podo F. MR spectroscopy of the breast. Radiol Med 2008, 113:56-64.
21. Zhang B., Zhu B., Li M., Yuan L., Yuan L., Zhang X., et al. Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors. Acta Radiol 2012, 53:607-614.
22. Kwee T.C., Takahara T., Ochiai R., Nievelstein R.A., Luijten P.R. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008, 18:1937-1952.
23. Stadlbauer A., Bernt R., Gruber S., Bogner W., Pinker K., van der Riet W., et al. Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. Eur Radiol 2009, 19:2349-2356.
24. Koh D.M., Collins D.J. Diffusion weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007, 188:1622-1635.
25. Thoeny H.C., De Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007, 17:1385-1393.
26. Tamai K., Koyama T., Saga T., Umeoka S., Mikami Y., Fujii S., et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007, 26:682-687.
27. Tamai K., Koyama T., Saga T., Morisawa N., Fujimoto K., Mikami Y., et al. The utility of diffusion weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008, 18:723-730.
28. Ichikawa T., Erturk S.M., Motosugi U., Sou H., Iino H., Araki T., et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006, 187:181-184. [2355].
29. Cafagna D., Rubini G., Iuele F., Maggialetti N., Notaristefano A., Pinto D., et al. Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Radiol Med 2012, 117:293-311.
30. Chiu F.Y., Jao J.C., Chen C.Y., Liu G.C., Jaw T.S., Chiou Y.Y., et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005, 29:176-180.
31. Benndorf M., Schelhorn J., Dietzel M., Kaiser W.A., Baltzer P.A. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Eur J Radiol 2012, 81:e849-e853.
32. Sinha S., Lucas-Quesada F.A., Sinha U., DeBruhl N., Bassett L.W. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002, 15:693-704.
33. Kinoshita T., Yashiro N., Ihara N., Funatu H., Fukuma E., Narita M. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002, 26:1042-1046.
34. Woodhams R., Ramadan S., Stanwell P., Sakamoto S., Hata H., Ozaki M., et al. Diffusion-weighted imaging of the breast: principles and clinical applications. Radiographics 2011, 31:1059-1084.